TWO SIGMA INVESTMENTS, LP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 71 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$156,000
-78.7%
44,700
-44.0%
0.00%
-66.7%
Q4 2016$734,000
-59.8%
79,777
-48.5%
0.00%
-57.1%
Q3 2016$1,825,000
+56.4%
154,814
+71.7%
0.01%
+40.0%
Q2 2016$1,167,000
-79.9%
90,186
-75.1%
0.01%
-82.1%
Q1 2016$5,794,000
-25.5%
362,363
+33.3%
0.03%
-24.3%
Q4 2015$7,780,000
+13.3%
271,754
+42.2%
0.04%
+15.6%
Q2 2015$6,864,000
+70.7%
191,095
+96.9%
0.03%
+45.5%
Q1 2014$4,021,000
+928.4%
97,057
+767.8%
0.02%
+1000.0%
Q3 2013$391,00011,1840.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2013
NameSharesValueWeighting ↓
Orbimed Advisors 3,028,354$30,526,0000.37%
Engineers Gate Manager LP 96,105$969,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 61,600$621,0000.06%
GAM Holding AG 83,940$846,0000.03%
SHELL ASSET MANAGEMENT CO 90,282$910,0000.02%
SFMG, LLC 11,994$107,0000.02%
QS Investors, LLC 159,133$1,604,0000.02%
Winslow, Evans & Crocker, Inc. 4,060$42,0000.01%
PANAGORA ASSET MANAGEMENT INC 285,646$2,879,0000.01%
PEAK6 Investments LLC 225,800$2,276,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders